Report Detail
Global Oral Mucositis Drugs Market Growth 2019-2024
- RnM3072366 |
- 07 March, 2019 |
- Global |
- 165 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
The classification of Oral Mucositis Drugs includes Mouthwash, Pain Control Medication and Other, the sales of Mouthwash are 16.9 million units, with its market share 48.8%. And the sales market share of Pain Control Medication is 38% in 2017.
Oral Mucositis Drugs is widely used to Chemotherapy Oral Mucositis and Radiotherapy Oral Mucositis. The most proportion of Oral Mucositis Drugs is to Radiotherapy Oral Mucositis, and the proportion is about 69.6% in 2017.
North America region is the largest supplier of Oral Mucositis Drugs, with a production market share nearly 53.6% in 2017. Europe is the second largest supplier of Oral Mucositis Drugs, enjoying production market share nearly 33.2% in 2017.
North America is the largest sales place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 26.9% in 2017. China is an important market of Oral Mucositis Drugs in Asia, accounting for 7.6% sales market share of global market.
According to this study, over the next five years the Oral Mucositis Drugs market will register a 8.0% CAGR in terms of revenue, the global market size will reach US$ 640 million by 2024, from US$ 400 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Mucositis Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Mucositis Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Oral Mucositis Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Mouthwash
Pain Control Medication
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Chemotherapy
Radiotherapy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Biovitrum
Valeant Pharmaceuticals
EUSA Pharma
Camurus
Mission Pharmacal
Clinigen Group
Midatech Pharma
Alliance Pharma
AMAG Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Oral Mucositis Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Oral Mucositis Drugs market by identifying its various subsegments.
Focuses on the key global Oral Mucositis Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Mucositis Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oral Mucositis Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Oral Mucositis Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Oral Mucositis Drugs Consumption 2014-2024
- 2.1.2 Oral Mucositis Drugs Consumption CAGR by Region
- 2.2 Oral Mucositis Drugs Segment by Type
- 2.2.1 Mouthwash
- 2.2.2 Pain Control Medication
- 2.2.3 Other
- 2.3 Oral Mucositis Drugs Consumption by Type
- 2.3.1 Global Oral Mucositis Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Oral Mucositis Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Oral Mucositis Drugs Sale Price by Type (2014-2019)
- 2.4 Oral Mucositis Drugs Segment by Application
- 2.4.1 Chemotherapy
- 2.4.2 Radiotherapy
- 2.5 Oral Mucositis Drugs Consumption by Application
- 2.5.1 Global Oral Mucositis Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Oral Mucositis Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Oral Mucositis Drugs Sale Price by Application (2014-2019)
3 Global Oral Mucositis Drugs by Players
- 3.1 Global Oral Mucositis Drugs Sales Market Share by Players
- 3.1.1 Global Oral Mucositis Drugs Sales by Players (2017-2019)
- 3.1.2 Global Oral Mucositis Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Oral Mucositis Drugs Revenue Market Share by Players
- 3.2.1 Global Oral Mucositis Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Oral Mucositis Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Oral Mucositis Drugs Sale Price by Players
- 3.4 Global Oral Mucositis Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Oral Mucositis Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Oral Mucositis Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Oral Mucositis Drugs by Regions
- 4.1 Oral Mucositis Drugs by Regions
- 4.1.1 Global Oral Mucositis Drugs Consumption by Regions
- 4.1.2 Global Oral Mucositis Drugs Value by Regions
- 4.2 Americas Oral Mucositis Drugs Consumption Growth
- 4.3 APAC Oral Mucositis Drugs Consumption Growth
- 4.4 Europe Oral Mucositis Drugs Consumption Growth
- 4.5 Middle East & Africa Oral Mucositis Drugs Consumption Growth
5 Americas
- 5.1 Americas Oral Mucositis Drugs Consumption by Countries
- 5.1.1 Americas Oral Mucositis Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Oral Mucositis Drugs Value by Countries (2014-2019)
- 5.2 Americas Oral Mucositis Drugs Consumption by Type
- 5.3 Americas Oral Mucositis Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Oral Mucositis Drugs Consumption by Countries
- 6.1.1 APAC Oral Mucositis Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Oral Mucositis Drugs Value by Countries (2014-2019)
- 6.2 APAC Oral Mucositis Drugs Consumption by Type
- 6.3 APAC Oral Mucositis Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Oral Mucositis Drugs by Countries
- 7.1.1 Europe Oral Mucositis Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Oral Mucositis Drugs Value by Countries (2014-2019)
- 7.2 Europe Oral Mucositis Drugs Consumption by Type
- 7.3 Europe Oral Mucositis Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Oral Mucositis Drugs by Countries
- 8.1.1 Middle East & Africa Oral Mucositis Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Oral Mucositis Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Oral Mucositis Drugs Consumption by Type
- 8.3 Middle East & Africa Oral Mucositis Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Oral Mucositis Drugs Distributors
- 10.3 Oral Mucositis Drugs Customer
11 Global Oral Mucositis Drugs Market Forecast
- 11.1 Global Oral Mucositis Drugs Consumption Forecast (2019-2024)
- 11.2 Global Oral Mucositis Drugs Forecast by Regions
- 11.2.1 Global Oral Mucositis Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Oral Mucositis Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Oral Mucositis Drugs Forecast by Type
- 11.8 Global Oral Mucositis Drugs Forecast by Application
12 Key Players Analysis
- 12.1 3M Healthcare
- 12.1.1 Company Details
- 12.1.2 Oral Mucositis Drugs Product Offered
- 12.1.3 3M Healthcare Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 3M Healthcare News
- 12.2 GSK
- 12.2.1 Company Details
- 12.2.2 Oral Mucositis Drugs Product Offered
- 12.2.3 GSK Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 GSK News
- 12.3 Pfizer
- 12.3.1 Company Details
- 12.3.2 Oral Mucositis Drugs Product Offered
- 12.3.3 Pfizer Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Pfizer News
- 12.4 Colgate-Palmolive
- 12.4.1 Company Details
- 12.4.2 Oral Mucositis Drugs Product Offered
- 12.4.3 Colgate-Palmolive Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Colgate-Palmolive News
- 12.5 Norgine
- 12.5.1 Company Details
- 12.5.2 Oral Mucositis Drugs Product Offered
- 12.5.3 Norgine Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Norgine News
- 12.6 Biovitrum
- 12.6.1 Company Details
- 12.6.2 Oral Mucositis Drugs Product Offered
- 12.6.3 Biovitrum Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Biovitrum News
- 12.7 Valeant Pharmaceuticals
- 12.7.1 Company Details
- 12.7.2 Oral Mucositis Drugs Product Offered
- 12.7.3 Valeant Pharmaceuticals Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Valeant Pharmaceuticals News
- 12.8 EUSA Pharma
- 12.8.1 Company Details
- 12.8.2 Oral Mucositis Drugs Product Offered
- 12.8.3 EUSA Pharma Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 EUSA Pharma News
- 12.9 Camurus
- 12.9.1 Company Details
- 12.9.2 Oral Mucositis Drugs Product Offered
- 12.9.3 Camurus Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Camurus News
- 12.10 Mission Pharmacal
- 12.10.1 Company Details
- 12.10.2 Oral Mucositis Drugs Product Offered
- 12.10.3 Mission Pharmacal Oral Mucositis Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Mission Pharmacal News
- 12.11 Clinigen Group
- 12.12 Midatech Pharma
- 12.13 Alliance Pharma
- 12.14 AMAG Pharmaceuticals
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Oral Mucositis Drugs. Industry analysis & Market Report on Oral Mucositis Drugs is a syndicated market report, published as Global Oral Mucositis Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Oral Mucositis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
